Semin intervent Radiol 2020; 37(05): 518-526
DOI: 10.1055/s-0040-1720949
Review Article

Hepatic Metastasis from Breast Cancer

Ariel N. Liberchuk
1   Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
,
Amy R. Deipolyi
1   Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
› Institutsangaben

Funding This research was funded through the NIH/NCI Cancer Center Support Grant P30 CA008748. A.R.D. reports personal fees from BTG, Inc. and from Dova Pharmaceuticals, outside the submitted work.
Preview

Abstract

Breast cancer is the most common cancer in women and breast cancer liver metastasis may be associated with poor outcomes. Emerging locoregional therapies can be given in outpatient settings or with short hospital stays, to provide local control, support quality of life, preserve liver function, and potentially prolong survival. This review discusses retrospective studies suggesting potential benefits of locoregional treatment of breast cancer liver metastasis. Future prospective studies are needed to demonstrate efficacy and optimize patient selection.



Publikationsverlauf

Artikel online veröffentlicht:
11. Dezember 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA